The Importance of the endogenous cannabinoid system in various neuropsychiatric disorders;Die bedeutung des endogenen Cannabinoidsystems bei verschiedenen neuropsychiatrischen erkrankungen

Fortschritte der Neurologie Psychiatrie

Volumn 68, Issue 10, 2000, Pages 433-438

  Schneider, U ^a   Muller Vahl, K R ^a   Stuhrmann, M ^a   Gadzicki, D ^a   Heller, D ^a   Seifert, J ^a   Emrich, H M ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; CANNABINOID; CANNABINOID RECEPTOR; OPIATE; OPIATE RECEPTOR;

ARTICLE; BASAL GANGLION; BRAIN ISCHEMIA; CENTRAL NERVOUS SYSTEM; CEREBELLUM; GILLES DE LA TOURETTE SYNDROME; HIPPOCAMPUS; HUMAN; LYMPHOCYTE; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; OPIATE ADDICTION; REINFORCEMENT; SCHIZOPHRENIA; SPLEEN;

ANIMALS; BRAIN ISCHEMIA; ENDOCANNABINOIDS; HUMANS; MENTAL DISORDERS; NERVOUS SYSTEM DISEASES; OPIOID-RELATED DISORDERS; RECEPTORS, CANNABINOID; SCHIZOPHRENIA; TOURETTE SYNDROME;

EID: 0033753664     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-7734     Document Type: Article

References (59)

1. Bockade of cannabinoid receptors by SR141716 selectively increases Fos expression in rat mesocorticolimbic areas via reduced dopamine D2 function
2. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts
3. Cannabinoid receptors and their endogenous agonist, anandamide
4. Cannabis and schizophrenia: Results of a follow-up study
5. Psychosis after cannabis abuse
6. Cannabinoid receptor gene (CNR1): Association with i.v. drug use
7. Maintenance of depression in chronic cannabis intoxication
8. Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization
9. Determination and characterization of a cannabinoid receptor in rat brain
10. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
11. Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes
12. Formation and inactivation of endogenous cannabinoid anandamide in central neurons
13. Cannabiskonsum und Verlauf schizophrener Psychosen
14. Reduced binocular depth inversion as an indicator of cannabis-induced censorship impairment
15. Towards a Cannabinoid-Hypothesis of Psychosis: Cognitive impairments due to a dysregulation of the endogenous cannabinoid system
16. A frequent polymorphism in the coding exon of the human cannabinoid receptor (CNR1) gene
17. The shifting importance of alcohol and marijuana as gateway substances among serious drug abusers
18. Hippocampal 5-HT receptors and consolidation of stressful memories
19. Marijuana use and psychiatric illness
20. Marijuana modified mania
21. Effective treatment of Tourette's syndrome with Marihuana
22. Cannabinoid receptor localization in brain
23. Cannabis and schizophrenia
24. Drogenabhangigkeit und Kontrolle. Kriminologische Untersuchung uber Phanomenologie des Heroinkonsums und polizeiliche Drogenkontrolle
25. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice
26. Dexanabinol; a novel neuroprotective drug in experimental focal cerebral ischemia
27. Elevated endogenous cannabinoids in schizophrenia
28. Cannabis abuse and the course of recent-onset schizophrenic disorders
29. Distribution of neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistry
30. [1231]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder
31. Localization of cannabinoid receptor mRNA in rat brain
32. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
33. Methylphenidate role in Tourette syndrome prevalence
34. Brain perfusion abnormalities in Gilles de la Tourette's syndrome
35. Cannabinoids: Possible role in pathophysiology and therapy of Gilles de la Tourette-Syndrome
36. Treatment of Tourette, Syndrome with delta-9-Tetrahydrocannabinol
37. Dopamine D2 receptor imaging in Gilles de la Tourette syndrome
38. Molecular characterization of a peripheral receptor for cannabinoids
39. Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures
40. An acute dose of delta-9-tetrahydrocannabinol affects behavioral and neurochemical indices of mesolimbic dopaminergic activity
41. Early cannabinoid exposure as a source of vulnerability to opiate addiction: A model in laboratory rodents
42. CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats
43. The effects of cannabis use on the clinical condition of schizophrenics
44. Pharmacology of cannabinoid CB1 and CB2 receptors
45. The Tourette syndrome diagnostic confidence index: Development and clinical associations
46. Tourette syndrome, associated conditions and the complexities of treatment
47. Acute effects of delta-9-tetrahydrocannabinol on dopaminergic activity in several rat brain areas
48. Cannabis-associated psychosis with hypomanic features
49. Delta-9-tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture
50. Tc-99m HMPAO SPECT brain imaging of Gilles de la Tourette's syndrome
51. Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats
52. A mutation in the human cannabinoid receptor (CNR1) gene in patients with Gilles de la Tourette syndrome
53. Zur Psychopathologie und Differentialdiagnose sogenannter Cannabispsychosen
54. Does substance abuse precipitate the onset of functional psychosis
55. Cannabis psychosis and paranoid schizophrenia
56. Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: Reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors
57. Cannabis and psychosis. Is there epidemiological evidence for an association?
58. The central cannabinoid receptor (CB1) mediates inhibition of nitric oxide production by rat microglial cells
59. Antipsychotic effect of cannabidiol